BRIEF-BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine
November 20, 2017 at 09:24 AM EST
* BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax's universal flu vaccine